NASDAQ:IBRX | EBITDA | ImmunityBio, Inc.

Complete source-backed ebitda history.

Available history
2014-12-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$65.41M
2025-12-31-$60.82M
2025-03-31-$60.6M
2024-12-31-$65.26M
2024-03-31-$90.64M
2023-12-31-$80.83M
2023-03-31-$106.9M
2022-12-31-$79.67M
2022-03-31-$91.88M
2021-12-31-$75.68M
2021-03-31-$83.29M
2020-12-31-$65.16M
2020-03-31-$33.24M
2019-12-31-$97.32M
2019-03-31-$15.94M
2018-12-31-$14.93M
2018-03-31-$26.66M
2017-12-31-$23.83M
2017-03-31-$24.3M
2016-12-31-$23.31M
2016-03-31-$31.13M
2015-12-31-$29.43M
2015-03-31-$32.08M
2014-12-31-$2.66M

Annual EBITDA

DateEBITDA
2025-12-31-$240.5M
2024-12-31-$326.63M
2023-12-31-$343.74M
2022-12-31-$333.04M
2021-12-31-$316.04M
2020-12-31-$208.14M
2019-12-31-$142.21M
2018-12-31-$88.83M
2017-12-31-$93.55M
2016-12-31-$120.89M
2015-12-31-$237.4M
2014-12-31-$5.54M